NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT
The major heart attack in the carotid system, going with the cerebral edema is considered to date as the most mortal type of the ischemic stroke. The only prove successful treatment policy is the decompressive craniectomy. The early start of the operative intervention, reported in the references, br...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2017-11-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/31 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850028664136138752 |
|---|---|
| author | T. Yu. Shaytanova V. A. Saskin E. V. Nedashkovsky |
| author_facet | T. Yu. Shaytanova V. A. Saskin E. V. Nedashkovsky |
| author_sort | T. Yu. Shaytanova |
| collection | DOAJ |
| description | The major heart attack in the carotid system, going with the cerebral edema is considered to date as the most mortal type of the ischemic stroke. The only prove successful treatment policy is the decompressive craniectomy. The early start of the operative intervention, reported in the references, brings about improvement of the clinical outcomes, however under limited time the diagnostics issues remain open and, as a consequence there perform the unreasonable traumatic operational assistance. 43 patients with the severe ischemic stroke were examined and an analysis of the S100-b glial peptide as a marker of malignant brain infarction course was performed. The neuropeptide monitoring in the blood serum allows detection of the responders to the decompressive craniectomy among the high-risk patients within 12-16 hours of the disease onset till the clinical deterioration development, when according to the computerized tomography the certain changes have not in yet. |
| format | Article |
| id | doaj-art-6492fd4c65b848ee9fda0ec627a81230 |
| institution | DOAJ |
| issn | 2078-5658 2541-8653 |
| language | Russian |
| publishDate | 2017-11-01 |
| publisher | New Terra Publishing House |
| record_format | Article |
| series | Вестник анестезиологии и реаниматологии |
| spelling | doaj-art-6492fd4c65b848ee9fda0ec627a812302025-08-20T02:59:46ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532017-11-01123485510.21292/2078-5658-2015-12-3-48-5531NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENTT. Yu. Shaytanova0V. A. Saskin1E. V. Nedashkovsky2E. E. Volosevich First Municipal Clinical Hospital, ArkhangelskE. E. Volosevich First Municipal Clinical Hospital, ArkhangelskNorthern State Medical University, ArkhangelskThe major heart attack in the carotid system, going with the cerebral edema is considered to date as the most mortal type of the ischemic stroke. The only prove successful treatment policy is the decompressive craniectomy. The early start of the operative intervention, reported in the references, brings about improvement of the clinical outcomes, however under limited time the diagnostics issues remain open and, as a consequence there perform the unreasonable traumatic operational assistance. 43 patients with the severe ischemic stroke were examined and an analysis of the S100-b glial peptide as a marker of malignant brain infarction course was performed. The neuropeptide monitoring in the blood serum allows detection of the responders to the decompressive craniectomy among the high-risk patients within 12-16 hours of the disease onset till the clinical deterioration development, when according to the computerized tomography the certain changes have not in yet.https://www.vair-journal.com/jour/article/view/31s100-bbiomarkersischemic strokemalignant cerebral edemadecompressive craniectomy |
| spellingShingle | T. Yu. Shaytanova V. A. Saskin E. V. Nedashkovsky NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT Вестник анестезиологии и реаниматологии s100-b biomarkers ischemic stroke malignant cerebral edema decompressive craniectomy |
| title | NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT |
| title_full | NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT |
| title_fullStr | NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT |
| title_full_unstemmed | NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT |
| title_short | NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT |
| title_sort | neuropeptide s100 b the diagnosis of a malignant cerebrovascular accident |
| topic | s100-b biomarkers ischemic stroke malignant cerebral edema decompressive craniectomy |
| url | https://www.vair-journal.com/jour/article/view/31 |
| work_keys_str_mv | AT tyushaytanova neuropeptides100bthediagnosisofamalignantcerebrovascularaccident AT vasaskin neuropeptides100bthediagnosisofamalignantcerebrovascularaccident AT evnedashkovsky neuropeptides100bthediagnosisofamalignantcerebrovascularaccident |